Woman experiencing mood swings and emotional changes associated with perimenopause.
Menopause is not a disease — it's a natural biological transition that every woman who lives long enough will experience. But the symptoms that accompany it can be genuinely disruptive, and in India, they are significantly under-discussed and undertreated. Many women assume that hot flushes, sleep problems, and mood changes are simply the price of aging and don't know that effective treatments exist.
Indian women reach menopause earlier than Western women — the median age is 46–48 years in India, compared to 51–52 in the West. This means more years of menopause-related hormonal effects, including on bone density, cardiovascular risk, and cognitive function.
Menopause is defined as 12 consecutive months without a menstrual period, in the absence of other causes (pregnancy, illness, medication). The average age of natural menopause in India is approximately 46–48 years.
Perimenopause: the transitional phase leading up to menopause — typically beginning 4–10 years before the final period. Hormone levels fluctuate irregularly as the ovarian reserve declines. This is when most menopausal symptoms begin.
Postmenopause: the phase after menopause has occurred. Estrogen levels remain low; many symptoms gradually improve over time, but some health risks (bone loss, cardiovascular) persist.
Premature ovarian insufficiency (POI): menopause before age 40. Requires medical evaluation and typically hormone replacement to protect bone density and cardiovascular health.
The most characteristic menopause symptoms. Hot flushes are sudden, intense sensations of heat spreading across the face, neck, and chest, often accompanied by sweating, reddening of the skin, and a feeling of the heart beating faster. They last 1–5 minutes typically. Night sweats are hot flushes during sleep, causing waking with drenching perspiration.
Experienced by approximately 75% of Western women; the prevalence in Indian women appears somewhat lower but remains highly significant — many Indian women dismiss hot flushes as insignificant or attributable to external heat without recognising them as menopausal.
The cause: falling estrogen disrupts the hypothalamic thermostat, producing erratic temperature regulation. Triggers that worsen them include hot drinks, spicy food, alcohol, and warm environments.
Frequency and impact vary widely: some women have a few mild flushes daily; others have 15–20 severe episodes daily that significantly disrupt sleep and daily function.
Night sweats disrupt sleep. But beyond night sweats, menopause independently affects sleep architecture — reducing deep sleep and REM sleep, increasing nighttime waking. Insomnia becomes more common. Sleep deprivation compounds fatigue, mood changes, and cognitive difficulties.
Irritability, anxiety, and low mood are common in perimenopause. Estrogen has complex effects on serotonin and dopamine signalling; its fluctuation and decline affects mood regulation. Women who previously never experienced significant mood symptoms may develop anxiety or depression during perimenopause.
This is not "imagined" or "just psychological" — it is a neurochemical effect of hormonal change, and responds to hormonal as well as psychological treatment.
Depression during perimenopause is a distinct entity from depression at other life stages and should not be treated with antidepressants alone without considering the hormonal context.
Many women describe difficulty concentrating, forgetfulness, and reduced mental sharpness during perimenopause. This is consistent with estrogen's known role in supporting cognitive function — estrogen receptors are present throughout the brain, and their activation supports memory consolidation, attention, and verbal fluency.
This typically improves once the transition is complete and hormonal fluctuations stabilise. Severe or progressive cognitive change warrants medical evaluation to rule out other causes.
The vaginal lining is highly estrogen-dependent. As estrogen falls, the vaginal walls thin, lose elasticity, and reduce natural lubrication. This causes:
These symptoms — collectively called the genitourinary syndrome of menopause (GSM) — are present in up to 50% of postmenopausal women and often become more significant over time (unlike hot flushes which tend to improve). They are significantly undertreated in India, partly because of cultural barriers to discussing sexual and urinary symptoms with a doctor.
The first sign of perimenopause is usually a change in cycle pattern — cycles may become shorter initially (every 21–25 days), then lengthen, become irregular, and eventually rare before stopping. The period itself may become heavier or lighter.
Heavy periods during perimenopause are common (from anovulatory cycles with prolonged estrogen stimulation without progesterone balance) and can cause or worsen iron deficiency. These should be evaluated by a gynaecologist to rule out other causes (fibroids, endometrial pathology).
Estrogen is bone-protective. In the first 5 years after menopause, bone density can decline by 3–5% annually — a rapid loss far exceeding the normal aging-related rate. This is the critical window for fracture prevention. Early postmenopausal women who experience significant bone loss without intervention are at high risk for fractures (hip, vertebral, wrist) in their 60s and 70s.
Calcium (1,200 mg daily), vitamin D (1,000–2,000 IU daily), weight-bearing exercise, and — when bone loss is significant — bisphosphonates or hormone replacement therapy are the preventive tools.
Before menopause, women have lower cardiovascular risk than men of the same age — partly from estrogen's protective effects on blood vessel function, lipid profiles, and inflammation. After menopause, this relative protection is lost and cardiovascular risk in women approaches and eventually exceeds that of men.
Managing blood pressure, cholesterol, blood sugar, and weight — and being more proactive about cardiovascular screening — becomes more important after menopause.
Most women experience perimenopause for 4–8 years before their final period. The experience is highly variable — some transition relatively smoothly with mild symptoms; others have significant symptoms for years.
The intensity of symptoms does not predict long-term health outcomes. Some women with mild symptoms have significant bone loss; some with severe symptoms don't.
HRT is the most effective treatment for menopausal symptoms — particularly vasomotor symptoms, sleep disruption, mood changes, and vaginal dryness. In women who began HRT close to menopause onset (the "window of opportunity"), it also reduces cardiovascular risk and fracture risk.
HRT involves estrogen (and progestogen for women who have a uterus, to protect the uterine lining from estrogen-driven overgrowth). Modern HRT formulations at the lowest effective dose for the shortest necessary time are far safer than the older formulations that drove the Women's Health Initiative concern in 2002.
Current evidence:
This is a conversation to have with a gynaecologist — not a decision to make alone or avoid entirely based on outdated fears.
For women who cannot or choose not to take HRT:
For genitourinary syndrome of menopause — vaginal dryness, discomfort with intercourse, recurrent UTIs — local vaginal estrogen (cream, pessary, or ring) is highly effective and safe. The amount absorbed systemically is minimal; it's appropriate even for women with a history of breast cancer in most guidelines.
This is a significantly underused treatment in India. Women with vaginal dryness causing significant discomfort should know this option exists.
Triggers reduction: identify and reduce hot flush triggers — spicy food, hot drinks, alcohol, caffeine, warm clothing layers.
Sleep hygiene: consistent sleep timing, cool room temperature, cotton clothing and bedding.
Exercise: reduces hot flush frequency and severity; improves mood; protects bone density and cardiovascular health.
Yoga and mindfulness: several trials show benefit for hot flush frequency and sleep quality.
Dietary calcium and vitamin D: essential for bone protection through the transition.
Phytoestrogens (soy isoflavones): weak estrogen-like compounds found in soy foods and some supplements. Meta-analyses show modest reduction in hot flush frequency. Soy milk, tofu, edamame, flaxseed. Less effective than HRT but without hormonal risks.
Any of the following warrant gynaecological evaluation:
At Prakash Hospital Noida, our gynaecologists provide comprehensive menopausal care — hormonal assessment, bone density screening referral, HRT counselling (including individualised risk-benefit discussion), local vaginal treatment, and management of perimenopausal symptoms.
Whether you live in Sector 18, Sector 62, Greater Noida West, or anywhere in the NCR, Prakash Hospital Noida is a trusted name for menopause management, women's health, and gynaecology in Noida.
Tags: #MenopauseSymptoms #PerimenopauseIndia #PrakashHospitalNoida
CopyWe offer expert care across key specialties, including Medicine, Cardiology, Orthopaedics, ENT, Gynaecology, and more—delivering trusted treatment under one roof.
Book a consultation with Prakash Hospital's specialists — 24/7 emergency care, 100+ doctors, NABH accredited.
Prakash Hospital Pvt. Ltd. is a 100 bedded NABH NABL accredited multispecialty hospital along with a center of trauma and orthopedics. We are in the service of society since 2001.
OUR SPECIALITIES
Patient Services
PROCEDURES
Contact Us
D – 12A, 12B, Sector-33, G. B. Nagar, Noida, Uttar Pradesh 201301
+91-8826000033
© 2026 All rights reserved.
Designed and Developed by Zarle Infotech
